A confidential S-1 is filed and bulge-bracket underwriters are named — but OpenAI's own statement says timing is undecided. The engine and the crowd read this the same way: a coin-flip leaning yes, not a lock.
The crowd gives this ~53%; after arguing both sides, superthesis lands at 57% — with an interval of 49–65% that reflects genuine uncertainty straight from the issuer's own mouth.
Public Benefit Corporation restructuring completed Oct 28, 2025
cleared
Goldman Sachs, Morgan Stanley, and JPMorgan engaged as lead underwriters
cleared
Microsoft exclusivity removed April 2026, clearing revenue-share audit trail for registration
cleared
Confidential S-1 filed May/June 2026; public registration statement and SEC comment rounds still pending
open
OpenAI management commits to a firm pre-2027 listing date — currently stated as undecided
The structural prerequisites are resolved: the PBC conversion closed Oct 28, 2025, a confidential S-1 is confirmed by OpenAI's own press release, and Goldman Sachs, Morgan Stanley, and JPMorgan are engaged — a sequence that fits a Q4 2026 listing under standard SEC 30–60-day review timelines with calendar buffer to spare.
Antithesis · the case against
OpenAI's own statement explicitly says the company 'has not decided on timing yet; it may be a while because there are things we want to do that are likely easier as a private company,' and the most concrete contractual IPO-trigger clause — Amazon's $35B tranche — carries an end-2028 deadline, leaving no contractual pressure to close before December 31, 2026.
Synthesis · the calibrated reading
The structural prerequisites for an OpenAI IPO before 2027 are largely in place: the PBC restructuring is confirmed at T1, an S-1 has been confidentially filed (T1 + multiple T2), lead underwriters are engaged, and a Q4 2026 target circulates across T2 outlets. However, the single most authoritative evidence on timing — OpenAI's own T1 official announcement — explicitly states the company 'has not decided on timing yet; it may be a while because there are things we want to do that are likely easier as a private company,' directly undercutting the urgency narrative. With no hard contractual deadline before 2027 (Amazon's IPO-trigger clause extends to end-2028) and a company that publicly…
0.57superthesis signal 0.49–0.65
0 · refutedcontestedconfirmed · 1.0
// the cases, gates, and the calibrated signal are from a live superthesis run on this claim. every source it weighed is listed below.
/ the evidenceevery claim, sourced
/ what the verdict is built on
The receipts. No black box.
superthesis cites what it reads. These are the sources weighed in the run above — open and auditable.
The market gives you a number. We give you the reasoning.
/ same claim · two ways of knowing
Polymarket · 0.53
superthesis · 0.57
0 · won't happen1.0 · will happen
A prediction market aggregates bets; superthesis aggregates arguments — it decomposes the claim, makes the strongest case on each side from sourced evidence, and reports a calibrated reading you can audit. The price says where the crowd sits; the verdict shows why.
Stop reading the odds. Read the evidence.
Point superthesis at any claim, market, or question — and watch it argue both sides, cite every source, and resolve a calibrated signal. Free while The Field is in early access.